Corient Private Wealth’s P3 Health Partners PIII Stock Holding History

Corient Private Wealth’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Sell	19,737 -100	-0.5%	-$744	﹤0.01%	2770
2026 Q1	$61.1K	Sell	19,837 -1,000	-5%	-$2.63K	﹤0.01%	2745
2025 Q4	$72.7K	Sell	20,837 -14,532	-41%	-$98.3K	﹤0.01%	2574
2025 Q3	$316K	Hold	35,369	–	–	﹤0.01%	2082
2025 Q2	$223K	Sell	35,369 -2,036	-5%	-$15.9K	﹤0.01%	2174
2025 Q1	$307K	Buy	37,405 +12,000	+47%	+$118K	﹤0.01%	1837
2024 Q4	$286K	Sell	25,405 -9,140	-26%	-$135K	﹤0.01%	1920
2024 Q3	$667K	Buy	+34,545	New	+$905K	﹤0.01%	1596

Other funds holding PIII

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TFA

Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

AWC

Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Corient Private Wealth's PIII Position: Q2 2026 in Review

Corient Private Wealth reduced its P3 Health Partners (PIII) stake by 0.5% in Q2 2026, selling an estimated $744 and leaving 19,737 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

Corient Private Wealth first reported a position in PIII in Q3 2024 and has held it in 8 quarters since. The position peaked at $667K in Q3 2024. 21 funds tracked by Wall St. Rank hold PIII as of Q2 2026.

Corient Private Wealth held 19,737 shares of P3 Health Partners worth $213K as of Q2 2026.
Corient Private Wealth sold 100 P3 Health Partners shares in Q2 2026, an estimated $744.
P3 Health Partners made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2770 holding.
Corient Private Wealth first reported a position in P3 Health Partners in Q3 2024 and has held it in 8 quarters since.
Corient Private Wealth's P3 Health Partners position peaked at $667K in Q3 2024.
21 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.